NCT02918955 2025-11-20
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed
Clinical Trials
8 trialsNCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
NCT03028766 2024-09-19
WISTERIA
University of Birmingham
Phase 1 Completed
NCT00833261 2020-08-21
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01445405 2019-12-17
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00169182 2019-02-15
Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Completed
NCT00508664 2015-06-02
DeLOS II
University of Leipzig
Phase 2 Completed
NCT00169247 2011-06-27
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed